Clinical trials
Terminated Leukemia, Myeloid, Acute trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
430 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 5 |
| 2004 | 7 |
| 2005 | 7 |
| 2006 | 16 |
| 2007 | 22 |
| 2008 | 18 |
| 2009 | 17 |
| 2010 | 19 |
| 2011 | 16 |
| 2012 | 14 |
| 2013 | 16 |
| 2014 | 22 |
| 2015 | 30 |
| 2016 | 26 |
| 2017 | 29 |
| 2018 | 28 |
| 2019 | 24 |
| 2020 | 27 |
| 2021 | 31 |
| 2022 | 17 |
| 2023 | 14 |
| 2024 | 6 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 430 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 33 |
| Fred Hutchinson Cancer Center | 19 |
| Masonic Cancer Center, University of Minnesota | 17 |
| National Cancer Institute (NCI) | 14 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 9 |
| Washington University School of Medicine | 9 |
| AbbVie | 8 |
| Celgene | 7 |
| City of Hope Medical Center | 7 |
| OHSU Knight Cancer Institute | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 430 |
| Myelodysplastic Syndromes | 144 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 121 |
| Leukemia | 108 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 67 |
| Congenital Abnormalities | 66 |
| Lymphoma, Non-Hodgkin | 61 |
| Multiple Myeloma | 60 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 53 |
| Hodgkin Disease | 51 |
Trials
Showing 1 to 25 of 430. Each trial links to its page on Pharma Observatory.
330 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.